Similar Search Results

Economies of scale of large-scale international development interventions : evidence from self-help groups in India

Siwach, Garima; Paul, Sohini; Hoop, Thomas de - In: World development : the multi-disciplinary … 153 (2022), pp. 1-16

Persistent link: https://www.econbiz.de/10013201775

Trastuzumab plus chemotherapy versus chemotherapy alone in HER2-positive gastric cancer treatment in Iran : a cost-effectiveness analysis

Kaveh, Sara; Ghadimi, Nashmil; Alvar, Amirhossein Zarei; … - 2024

Background Combining Trastuzumab with chemotherapy for HER2-positive gastric cancer shows treatment promise but may raise costs. We aimed to evaluate the cost-effectiveness of combining Trastuzumab with chemotherapy for HER2-positive gastric cancer treatment in Iran. Methods We employed a...

Persistent link: https://www.econbiz.de/10015371737

The role of knowledge management processes in leveraging competitive strategies to achieve firm innovativeness

Trivedi, Karishma; Srivastava, Kailash B.L. - In: The Bottom Line: Managing library finances 35 (2022) 2/3, pp. 53-72

Purpose This paper aims to examine the role of knowledge management (KM) processes in enhancing competitive strategies of differentiation and cost-effectiveness and its impact on innovativeness in knowledge-intensive service organizations (KISOs) in India. Design/methodology/approach This study...

Persistent link: https://www.econbiz.de/10014686890

Exploring the acceptability and cost-effectiveness of plastic bottle waste bricks in Nigeria's construction sector : a stakeholder perspective

Solaja, Oludele Mayowa; Onafeso, Olumide D.; … - In: The journal of environment & development : a review of … 34 (2025) 1, pp. 3-29

Persistent link: https://www.econbiz.de/10015372613

Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland

Paulissen, Jeroen H. J.; Seddik, Ahmed H.; Dunton, Kyle J. - In: The European Journal of Health Economics 25 (2023) 4, pp. 689-699

Objectives: Trastuzumab deruxtecan (T-DXd) was recently recommended by the Committee for Medicinal Products for Human Use as a treatment for adult patients with unresectable or metastatic HER2-positive breast cancer, who had received a prior anti-HER2-based regimen. In our study, we evaluated...

Persistent link: https://www.econbiz.de/10015404241